Built In, a platform connecting professionals with technology companies across the United States, announced today that it has raised $22 million in Series C funding. Updata Partners led the round, with participation from existing investors including MATH Venture Partners, which led Built In's previous two funding rounds. The company will use the funding to expand its national footprint, increase investments in its core product and further enhance opportunities for professional development in the technology industry.
Apervita announced today it was selected by Healthcare Tech Outlook Magazine as a top 10 artificial intelligence solution provider for 2019. Apervita is a healthcare cloud platform that allows enterprises to easily and quickly build analytic & data applications for a wide array of clinical, financial, and operational use cases. Along with numerous other healthcare-specific tools, Apervita allows artificial intelligence (AI) and machine learning (ML) to be embedded into any application.
Every kid is different. Some remain still, focused and content with their books or Legos. Others get on a sled, immediately rocket into a snowy woods, and disappear for days on end. (Just kidding.) (Kind of.)
As a parent, it can be hard to know when to grab your children and when to pull back. But on a recent sunny, Saturday morning, in a mostly empty park, I decided to try something different. When my four-year-old took off down the trail, I resisted the urge to sprint after her. Instead, I opened the Jiobit app and turned on Live Mode.
I watched as the little dot got about 400 feet away from me, walked in uncertain circles at a fork in the trail, then turned around. As it turns out, a little bit of freedom goes a long way.
This article was originally published on Apervita.com.
Pioneering Healthcare Platform-as-a-Service Now Connected to Approximately 1,000 Hospitals, Grows Annual Recurring Revenue More Than 1,000%
CHICAGO, Feb. 7, 2019 /PRNewswire/ — Apervita, Inc., the nation’s first healthcare cloud platform, today announced that it ended 2018 serving approximately 1,000 hospitals and is on track to support more than 3,000 hospitals by the end of 2019. At the same time, the company has doubled the number of applications built on its platform. This rapid market adoption led to a 1,000% growth in annual recurring revenue for the year ending in December 2018.
Healthcare stakeholders are looking to reduce costs across the board while improving clinical outcomes and operational efficiency. However, maintaining hundreds of separate point IT solutions in support of these cost reduction efforts is hugely costly and ultimately unsustainable. At the same time, government bodies like The Centers for Medicare and Medicaid Services and other industry associations are driving their customers and members to adopt electronic computable specifications.
Apervita’s secure, massively scalable Platform-as-a-Service (PaaS) allows healthcare stakeholders to build, connect and transact in the cloud across three main areas: quality performance, clinical pathways and data sharing. As a result, costs for stakeholders using Apervita are 70-80% less expensive than maintaining numerous point solutions. Additionally, stakeholders have complete control of their information, allowing them to share only what they need to, and avoid technical, business and privacy issues associated with legacy data sharing processes.
“The healthcare industry is at a digital inflection point,” said Apervita President Ken Jakobsen. “All stakeholders are looking to more fully leverage their IT spend and operations. We are leading the transformation effort from individually developed, maintained and paid for software solutions, to those developed on a cloud platform. The market’s rapid adoption of our platform is a testament to its powerful value proposition and is analogous to experiences in other industries.”
To help direct and further accelerate its growth, Apervita also announced that industry veteran Kevin Weinstein has been named Chief Growth Officer. Weinstein has a proven track record of scaling high-growth healthcare enterprises. Prior to Apervita, he most recently served as CEO of Analyte Health. His other experience includes Chief Growth Officer at Valence Health (acquired by Evolent), and executive positions at ZirMed (acquired by Bain Capital) and Allscripts.
“We are fortunate to have someone with Kevin’s background of successfully building and scaling healthcare startups to drive value for our customers,” Apervita founder and CEO Paul Magelli said. “Kevin will add tremendous value as we cement our position as the industry-leading healthcare cloud platform.”
“I’ve worked in healthcare for two decades and have never seen this type of opportunity,” said Weinstein. “The growth Apervita experienced in 2018 is clearly just the tip of the iceberg. I’m excited to bring the power of Apervita’s cloud platform to an ever-increasing group of healthcare customers and partners. Apervita is a true game changer in improving outcomes and lowering costs across the entire healthcare ecosystem.”
Apervita, Inc. is the first healthcare Platform-as-a-Service (PaaS) that allows providers, payers and the health enterprises that support them to easily build and share applications that decrease cost, improve patient and clinician experience, and improve outcomes. With Apervita, health enterprises can collaborate freely and securely within and outside of their organizations, streamlining, standardizing and auditing quality measures, operational metrics and care pathways. Apervita is used by approximately 1,000 hospitals nationwide.
Headquarters Chicago, IL
Approx. 1,000 hospitals connected
Customers in all 50 states
Gartner Cool Vendor
First company to offer Clinical Quality Language execution services
This article was originally published on PRNewswire.
CHICAGO, Feb. 7, 2019 /PRNewswire/ -- rMark Bio, which delivers AI solutions that accelerate innovation and scientific discoveries for life sciences companies, recently closed $1.5 million in growth funding. Lincoln Park Capital led the Seed funding along with support from investors M25 Group, SaaS Ventures and MATH Venture Partners.
"We appreciate that investors recognize our unique value proposition. Our ability to help accelerate innovation, especially in highly complex life sciences fields such as therapeutic development, by effectively analyzing and aligning internal and external data with their business strategies, means we help them bring their data to life for the ultimate benefit of patients," said Jason M. Smith, rMark Bio co-founder and CEO. "This vital funding ensures we are able to expand our ability to bring our end-to-end intelligence solutions to companies that want to harness the transformative power of their data but struggle with how to make it a reality."
With the close of investment, MATH Venture Partners Managing Director Mark Achler joined rMark Bio's Board of Directors. "I'm excited to be part of an AI venture that can help accelerate discovery and innovations within the life sciences and the healthcare industry," said Achler. "Jason and his team understand how to build AI in order to help define and deliver data-driven insights."
The funding will be used to grow rMark Bio through market expansion, enable the hiring of key personnel and support rMark Bio's transition into its new headquarters office at 440 N. Wells in Chicago.
Fabric, rMark Bio's patented platform, is an end-to-end AI solution that accelerates innovation and scientific discoveries for life sciences companies by fostering awareness and collaboration. The Fabric platform employs several key capabilities in a three-step process:
It enables automated aggregation and preparation of data for machine learning.
Neural networks are trained to analyze data and surface scientific insights and discoveries.
Fabric's APIs integrate with existing apps to deliver insights.
Specifically, Fabric is trained to understand petabytes of life sciences unstructured text, videos, voice, proteomics, genomic and free form data from existing business applications such as Microsoft™, Salesforce™ and Veeva™ along with third party data sources from IQVIA™ and Symphony Heath™. Working in unison, Fabric's neural networks surface the most relevant insights and discoveries based on each department or user's specific business needs, without the cost of multiple systems.
Fabric currently is licensed and deployed in several top-20 pharmaceutical companies who are benefitting from savings with its unified data intelligence solution. For example, rMark Bio is saving one customer millions of dollars during the next 12 months compared to what it would have spent for traditional SaaS or consulting services.
"Ahead of that customer's product launch, the Fabric platform provided its marketing department and commercial sales leadership with one-click access to real-time, compliant and, most importantly, relevant target lists," said Smith.
About rMark Bio
rMark Bio, Inc. was created to transform the life sciences and pharmaceutical industries by making artificial intelligence simple to adopt, easy to use and continuously transformative through a holistic approach incorporating strategy, technology and people power. Founded in 2015 by Jason M. Smith, CEO, and Lev Becker, Ph.D., Chief Scientist, rMark Bio is based in Chicago and Seattle. rMark Bio provides services to the top 20 pharmaceutical companies globally and has partnered with industry-leading technology and healthcare organizations, including Microsoft, nVidia, Apigee/Google, and MATTER.
This article was originally published on CardFlight here.
CardFlight’s three-year growth rate of over 2,900% placed the company on the 2018 list of fastest growing technology companies in North America.
New York, New York – CardFlight, the leading mobile POS and SaaS payment technology company, announced today that it ranked 48 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. CardFlight’s 2,916% three-year growth rate placed the company on this year’s list. Overall, 2018 Technology Fast 500™ companies achieved median growth of 412%.
Founded in 2013 and with operations in New York City and Lincoln, Nebraska, CardFlight prides itself on being the leader in payment technology and mobile point-of-sale solutions. The company partners with merchant service providers, banks, and independent sales organizations to serve more than 45,000 small businesses in all 50 U.S. states.
Derek Webster, CardFlight’s Founder and CEO, credits the company’s commitment to delivering superior products for enabling the company’s revenue growth. He said, “I’m proud and honored to see CardFlight recognized on Deloitte’s Fast 500 list. Our team works hard to deliver the best-in-class payment acceptance technology to our partners, and to enable them to serve tens of thousands of small businesses across the United States. The team’s talent and dedication enable CardFlight’s growth and success and I want to thank them. I would also like to thank Deloitte for honoring us on the Fast 500 list this year.”
“Congratulations to the Deloitte 2018 Technology Fast 500 winners on this impressive achievement,” said Sandra Shirai, vice chairman, Deloitte LLP, and U.S. technology, media and telecommunications leader. “These companies are innovators who have converted their disruptive ideas into products, services and experiences that can captivate new customers and drive remarkable growth.”
About Deloitte’s 2018 Technology Fast 500™
Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2014 to 2017.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.
The company, founded three years ago by former Motorola Mobility executives John Renaldi and Roger Ady, raised capital from Netgear, a Silicon Valley maker of wireless-networking equipment, as well as Math Venture Partners, Techstars Ventures, Wakestream Ventures, Sandalphon Capital, former Motorola and Google executive Lior Ron, Cartavi founder Glenn Shimkus and angel investor Sam Guren. Jiobit has now raised $11 million.
Spot Hero was chosen for finding a creative solution to a problem and “inventing the future,” as TIME put it.
To save its customers the stress of finding a parking spot, SpotHero allows users to prepay for one. Eliminating the need to circle downtown searching for parking curbs congestion and pollution too.